It suggests that the US should oppose the misuse of commercial spyware “to target individuals, including journalists, defenders of internationally recognized human rights, and members of civil society groups, members of ethnic or religious minority groups, and others for exercising their internationally recognized human rights and fundamental freedoms, or the family members of these targeted individuals.”
It also further stipulates that the US should coordinate with allies and partners to prevent the export of commercial spyware tools to end-users likely to use them for malicious activities, and to share information on this issue with allies robustly.
Evaluation of national security risks posed by foreign adversary acquisition of American multiomic data: The bill stipulates that not later than 270 days after its enactment, the director of national intelligence, in consultation with the secretary of defense, the US attorney general the secretary of health and humans services, the secretary of commerce, the secretary of homeland security, the secretary of state, and the national cyber director, shall complete an assessment of risks to national security posed by human multiomic data from US citizens that is collected or stored by a foreign adversary from the provision of biotechnology equipment or services. Multiomic data combines different types of biological data, such as genomics, transcriptomics, proteomics, and metabolomics, to provide a complete picture of a biological system.
